Brief: Little Green Pharma Says HY Revenue From Ordinary Activities Up 25%
29/11/2022 23:00
Nov 30 (Reuters) - Little Green Pharma Ltd LGP.AX :
* HY REVENUE FROM ORDINARY ACTIVITIES UP 25% TO A$9.2
MILLION
* HY LOSS AFTER TAX FROM CONTINUING OPERATIONS A$7.5 MILLION
VERSUS LOSS OF A$8.6 MILLION
Further company coverage: LGP.AX
((reuters.briefs@thomsonreuters.com;))
Recent news on Little Green Pharma
See all newsBrief: Little Green Pharma Says Cannatrek In Further Discussions With TGA In Relation To Investigation
Brief: Little Green Pharma Reports Qtrly Revenue Of A$12.5 Million
Brief: Little Green Pharma Announces Updated Second Court Date
Brief: Little Green Pharma Provides Scheme Update
Brief: Little Green Pharma Announces Termination Of Proposed Sale And Leaseback Transaction